未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Pharmacokinetics of AZD8630/AMG 104 inhaled anti-TSLP in healthy adults and asthma patients Asimus, Sara; Sadiq, Waqas Muhammad; Cooper, Jason; Dosanjh, Davinder; Zhou, Xiao-Hong; Pandya, Hitesh; Cushion, Michael; Podrimcaku, Valmira; Parnes, Jane; Abuqayyas, Lubna; Molfino, Nestor; Doffman, Sarah 分享 收藏
Proof of Mechanism for an inhaled anti-TSLP fragment antibody, AZD8630/AMG104, in a phase 1 study in healthy adults and asthma patients Scott, Ian C.; Kovacina, Kristina; Cardner, Mathias; Ghandi, Avni, V; Tran, Jenny; Terrillon, Sonia; Gorski, Kevin; Cooper, Jason; White, Nick; Waqas, Sara Asimus; Davinder, Sadiq; Dosanjh, P. S.; Rosenbaum, Anton; Parnes, Jane R.; Molfino, Nestor; Brohawn, Zach; Platt, Adam; Burns, Steve; Doffman, Sarah 分享 收藏
Time to first moderate or severe COPD exacerbation with tezepelumab (COURSE) Singh, Dave; Brightling, Christopher; Rabe, Klaus; Han, Meilan; Bhutani, Mohit; Bourbeau, Jean; Christenson, Stephanie; Dransfield, Mark; Nair, Parameswaran; Kotalik, Ales; Hellqvis, Asa; Almqvist, Gun; Sindhwani, Navreet; Golabek, Monika; Molfino, Nestor; Ponnarambil, Sandhia 分享 收藏
EFFICACY OF TEZEPELUMAB IN ADULTS WITH MODERATE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOOD EOSINOPHIL COUNT AND SMOKING HISTORY: PHASE 2A COURSE STUDY Han, Meilan K.; Christenson, Stephanie; Dransfield, Mark T.; Bourbeau, Jean; Bhutani, Mohit; Nair, Parameswaran K.; Singh, Dave; Bafadhel, Mona; Brightling, Christopher E.; Ambrose, Christopher S.; Kotalik, Ales; Hellqvist, Asa; Almqvist, Gun; Sindhwani, Navreet S.; Golabek, Monika; Molfino, Nestor; Ponnarambil, Sandhia 分享 收藏
分享 收藏
Tezepelumab can restore normal lung function in patients with severe, uncontrolled asthma Pavord, Ian Douglas; Brightling, Christopher E.; Korn, Stephanie; Martin, Nicole; Ponnarambil, Sandhia; Molfino, Nestor A.; Parnes, Jane R.; Cook, Bill; Ambrose, Christopher S. 分享 收藏
Biomarkers and clinical outcomes after cessation of tezepelumab after 2 years of treatment (DESTINATION)Biomarkers and clinical outcomes after cessation of tezepelumab after 2 years of treatment (DESTINATION) Brightling, Christopher E.; Jackson, David; Kotalik, Ales; Molfino, Nestor A.; Caveney, Scott; Colice, Gene; Martin, Neil; Israel, Elliot; Pavord, Ian D.; Wechsler, Michael E.; Porsbjerg, Celeste 分享 收藏
分享 收藏
分享 收藏
Disconnect for Tezepelumab on Exacerbations, Symptoms, and Quality of Life in Type 2 Low Asthma Reply Ambrose, Christopher S.; Israel, Elliot; Bowen, Karin; Llanos, Jean-Pierre; Martin, Neil; Cook, Bill; Hellqvist, Asa; Korn, Stephanie; Menzies-Gow, Andrew; Roseti, Stephanie L.; Molfino, Nestor A.; Griffiths, Janet M.; Parnes, Jane R. 分享 收藏
分享 收藏
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials Corren, Jonathan; Menzies-Gow, Andrew; Chupp, Geoffrey; Israel, Elliot; Korn, Stephanie; Cook, Bill; Ambrose, Christopher S.; Hellqvist, Asa; Roseti, Stephanie L.; Molfino, Nestor A.; Llanos, Jean-Pierre; Martin, Neil; Bowen, Karin; Griffiths, Janet M.; Parnes, Jane R.; Colice, Gene 分享 收藏
分享 收藏
分享 收藏
Effect of tezepelumab on the proportion of exacerbation-free patients with severe, uncontrolled asthma in NAVIGATOR 在NAVIGATOR中，tezepelumab对重度未控制哮喘患者无加重比例的影响 Korn, Stephanie; Bourdin, Arnaud; Chupp, Geoffrey; Colice, Gene; Ambrose, Christopher S.; Kmita, Kamil; Llanos-Ackert, Jean-Pierre; Molfino, Nestor; Cook, Bill 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
